cancer Archives - Mediformatica

Impact of Mobilization Facilitated by Wearable Device Enhanced Patient Monitoring/Electrophysiology Pod–Based Feedback on Postoperative Complications Following Colorectal Cancer Surgery: Randomized Controlled Trial

January 31, 2026January 31, 2026JMIR mHealth and uHealth

Background: Enhanced Recovery After Surgery (ERAS) guidelines recommend early postoperative mobilization to reduce complications, but adherence is often suboptimal, highlighting the need for effective tools to monitor and encourage movement. The Mindray ePM/ep pod,…

NHS genetics programme to track people at risk of inherited cancer

January 30, 2026January 30, 2026Digital Health

Professor Peter Johnson, NHS national cancer director (Image provided by NHS England)

People at higher risk of developing cancer because of inherited genes will be regularly checked and tracked by the NHS under a…

NHS AI and robot pilot to help detect lung cancer sooner

January 27, 2026January 27, 2026Digital Health

Dr Anne Rigg, medical director for cancer and surgery at Guy’s and St Thomas’ NHS Foundation Trust (Credit: Guy’s and St Thomas’ NHS Foundation Trust)

NHS England has launched an AI and robot pilot…

VieCure Raises $43 Million to Help Democratize Access | Avalon Healthcare Solutions Announces Strategic Investment

January 26, 2026January 26, 2026Healthcare IT Today

Check out today’s featured companies who have recently raised a round of funding, and be sure to check out the full list of past healthcare IT fundings.

VieCure Raises $43 Million to Help Democratize Access…

Government bid to end ‘postcode lottery’ for cancer-detecting tech

January 26, 2026January 26, 2026Digital Health

Professor Peter Johnson, NHS national cancer director (Image provided by NHS England)

The government has announced that it is investing in technology and AI to spot cancers earlier in a bid to help end…

The End of the Guessing Game: Why Primary Care is Finally Ready for Pharmacogenomics

January 23, 2026January 23, 2026HIT Consultant

Joel Diamond, MD, Co-Founder & Chief Medical Officer of Aranscia

Pharmacogenomics, also referred to as PGx, is the use of a patient’s genetic makeup to guide safer, more effective medication choices and dosing in everyday…

Topos Bio Secures $10.5M to Tackle ‘Undruggable’ Proteins | Oasys Raises $4.6M to Transform Mental Health Care

January 20, 2026January 20, 2026Healthcare IT Today

Check out today’s featured companies who have recently raised a round of funding, and be sure to check out the full list of past healthcare IT fundings.

Topos Bio Secures $10.5M to Tackle ‘Undruggable’ Proteins…

Oncology’s Largest Dataset: ConcertAI and Foundation Medicine Unveil Half-Million Patient Clinico-Genomic Powerhouse

January 15, 2026January 16, 2026HIT Consultant

What You Should Know

– ConcertAI and Foundation Medicine have announced a major strategic collaboration to integrate their massive data assets, creating a dataset of nearly half a million patients.

– By pairing Foundation Medicine’s de-identified…

Mitch Rales Leads $43M Round to Scale VieCure’s AI Oncology Platform

January 12, 2026January 13, 2026HIT Consultant

What You Should Know:

– VieCure has raised $43M led by Mitch Rales (co-founder of Danaher) and Northpond Ventures. The funding will scale VieCure’s Halo Intelligence™ platform, an AI-powered clinical decision support system that has…

VieCure raises $43M for cancer care platform

January 12, 2026January 12, 2026MobiHealthNews

VieCure raises $43M for cancer care platform | MobiHealthNews

Skip to main content…

Diverging trajectories of trust in healthcare and on-line information seeking: what’s next with LLMs

Weekly Roundup – January 31, 2026

Embedding clinical intelligence to help close care gaps

Impact of Mobilization Facilitated by Wearable Device Enhanced Patient Monitoring/Electrophysiology Pod–Based Feedback on Postoperative Complications Following Colorectal Cancer Surgery: Randomized Controlled Trial

Tag: cancer

Impact of Mobilization Facilitated by Wearable Device Enhanced Patient Monitoring/Electrophysiology Pod–Based Feedback on Postoperative Complications Following Colorectal Cancer Surgery: Randomized Controlled Trial

NHS genetics programme to track people at risk of inherited cancer

NHS AI and robot pilot to help detect lung cancer sooner

VieCure Raises $43 Million to Help Democratize Access | Avalon Healthcare Solutions Announces Strategic Investment

The End of the Guessing Game: Why Primary Care is Finally Ready for Pharmacogenomics

Topos Bio Secures $10.5M to Tackle ‘Undruggable’ Proteins | Oasys Raises $4.6M to Transform Mental Health Care

Oncology’s Largest Dataset: ConcertAI and Foundation Medicine Unveil Half-Million Patient Clinico-Genomic Powerhouse

Mitch Rales Leads $43M Round to Scale VieCure’s AI Oncology Platform

VieCure raises $43M for cancer care platform

Diverging trajectories of trust in healthcare and on-line information seeking: what’s next with LLMs

What impact has healow had on your organization and the patients’ experience?

Weekly Roundup – January 31, 2026

Embedding clinical intelligence to help close care gaps

Impact of Mobilization Facilitated by Wearable Device Enhanced Patient Monitoring/Electrophysiology Pod–Based Feedback on Postoperative Complications Following Colorectal Cancer Surgery: Randomized Controlled Trial

Meditech founder Neil Pappalardo dies at 83

The Landscape of Mobile Apps for Healthy Eating: Case Study for a Systematic Review and Quality Assessment

Decagon raises $250M for AI agents, triples valuation to $4.5B

Successful AI adoption requires meaningful change management

The Safe AI in Medicaid Alliance can help providers hone their tactics

MediFormatica

News Aggregator